RENEA JONES: Open Payments
NPI 1821411562 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,585 in 77 payments from 19 companies in 2025. Trend: 2023 $900 · 2024 $1,415 · 2025 $1,585
Food & beverage: $1,585
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $294 |
| Novo Nordisk Inc | 10 | $221 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $165 |
| Otsuka America Pharmaceutical, Inc. | 7 | $137 |
| PFIZER INC. | 8 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $97 |
| Lilly USA, LLC | 4 | $80 |
| Dexcom, Inc. | 4 | $69 |
| Mannkind Corporation | 3 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
Products named: JARDIANCE, REXULTI, AIRSUPRA, FARXIGA, Ozempic, CAPLYTA, PREVNAR 20, Rybelsus.
Industry payments across TN — which companies pay providers there.
